Datavault AI Inc. (NASDAQ: DVLT) has expanded its definitive licensing agreement with DataMeds AI Inc. (NASDAQ: MEDS) to extend its PharmacyChain blockchain-related technology beyond pharmaceutical distribution into commercial healthcare, healthspan and wellness applications. The expanded relationship is designed to support patient-controlled health data access, monetization and real-world asset tokenization across pharmacy, medical, laboratory and wearable device environments, leveraging a behavioral healthcare patent portfolio focused on medical logistics, IoT population health and AI-driven remote patient monitoring.
Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes. The companies said the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
This expansion is significant because it marks a strategic pivot for Datavault AI’s technology into the broader healthcare industry. By integrating blockchain and AI-driven data solutions into commercial healthcare, the company aims to give patients greater control over their health data, potentially transforming how medical information is shared and monetized. The move also opens up new revenue streams through real-world asset tokenization, which could impact industries ranging from pharmaceuticals to wearable technology.
Datavault AI is leading the way in AI-driven data experiences, valuation and monetization of assets in the Web 3.0 environment. Its cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Sciences and Data Sciences divisions. The Acoustic Sciences division features WiSA, ADIO and Sumerian patented technologies for spatial and multichannel wireless audio, while the Data Science division leverages Web 3.0 and high-performance computing for data perception, valuation and secure monetization.
The company’s platform serves multiple industries, including high-performance computing software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange enables Digital Twins and the licensing of name, image and likeness by securely attaching physical real-world objects to immutable metadata, fostering responsible AI with integrity.
For readers, this news matters because it signals a growing trend toward patient-centric data control in healthcare. As blockchain technology becomes more integrated into medical data management, individuals may soon have the ability to manage and monetize their own health information, potentially leading to more personalized and efficient healthcare services. Additionally, the expansion into commercial healthcare could accelerate the adoption of AI-driven remote patient monitoring and IoT population health solutions, improving outcomes and reducing costs.
To view the full press release, visit https://ibn.fm/vBAxH. For more information about Datavault AI, visit https://dvlt.ai.
